PBYI
Price
$3.33
Change
+$0.02 (+0.60%)
Updated
Jun 27 closing price
Capitalization
165.29M
31 days until earnings call
VYGR
Price
$2.96
Change
-$0.01 (-0.34%)
Updated
Jun 27 closing price
Capitalization
163.8M
31 days until earnings call
Interact to see
Advertisement

PBYI vs VYGR

Header iconPBYI vs VYGR Comparison
Open Charts PBYI vs VYGRBanner chart's image
Puma Biotechnology
Price$3.33
Change+$0.02 (+0.60%)
Volume$699.74K
Capitalization165.29M
Voyager Therapeutics
Price$2.96
Change-$0.01 (-0.34%)
Volume$1.09M
Capitalization163.8M
PBYI vs VYGR Comparison Chart in %
Loading...
PBYI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PBYI vs. VYGR commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBYI is a Buy and VYGR is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (PBYI: $3.33 vs. VYGR: $2.96)
Brand notoriety: PBYI and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PBYI: 193% vs. VYGR: 189%
Market capitalization -- PBYI: $165.29M vs. VYGR: $163.8M
PBYI [@Biotechnology] is valued at $165.29M. VYGR’s [@Biotechnology] market capitalization is $163.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PBYI’s FA Score shows that 1 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • PBYI’s FA Score: 1 green, 4 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, both PBYI and VYGR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PBYI’s TA Score shows that 3 TA indicator(s) are bullish while VYGR’s TA Score has 3 bullish TA indicator(s).

  • PBYI’s TA Score: 3 bullish, 3 bearish.
  • VYGR’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, PBYI is a better buy in the short-term than VYGR.

Price Growth

PBYI (@Biotechnology) experienced а +4.23% price change this week, while VYGR (@Biotechnology) price change was -2.63% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

PBYI is expected to report earnings on Jul 31, 2025.

VYGR is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PBYI($165M) and VYGR($164M) have the same market capitalization . VYGR has higher P/E ratio than PBYI: VYGR (6.32) vs PBYI (4.27). PBYI YTD gains are higher at: 9.180 vs. VYGR (-47.795). PBYI has higher annual earnings (EBITDA): 54.7M vs. VYGR (-97.25M). VYGR has more cash in the bank: 236M vs. PBYI (93.2M). VYGR has less debt than PBYI: VYGR (42M) vs PBYI (61.7M). PBYI has higher revenues than VYGR: PBYI (233M) vs VYGR (67M).
PBYIVYGRPBYI / VYGR
Capitalization165M164M101%
EBITDA54.7M-97.25M-56%
Gain YTD9.180-47.795-19%
P/E Ratio4.276.3268%
Revenue233M67M348%
Total Cash93.2M236M39%
Total Debt61.7M42M147%
FUNDAMENTALS RATINGS
PBYI vs VYGR: Fundamental Ratings
PBYI
VYGR
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
34
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1995
PRICE GROWTH RATING
1..100
5365
P/E GROWTH RATING
1..100
979
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYGR's Valuation (34) in the Biotechnology industry is in the same range as PBYI (37). This means that VYGR’s stock grew similarly to PBYI’s over the last 12 months.

VYGR's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PBYI (100). This means that VYGR’s stock grew similarly to PBYI’s over the last 12 months.

PBYI's SMR Rating (19) in the Biotechnology industry is significantly better than the same rating for VYGR (95). This means that PBYI’s stock grew significantly faster than VYGR’s over the last 12 months.

PBYI's Price Growth Rating (53) in the Biotechnology industry is in the same range as VYGR (65). This means that PBYI’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (9) in the Biotechnology industry is significantly better than the same rating for PBYI (97). This means that VYGR’s stock grew significantly faster than PBYI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PBYIVYGR
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
78%
Momentum
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
80%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
PBYI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VYGR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MGDDF38.550.75
+1.98%
CIE GENERALE DES ETABLISSEMENTS MICHELIN SA CLERMONT-FERRAND
FRSB15.01N/A
N/A
FIRST RESOURCE BANCORP INC.
MTWTF12.31N/A
N/A
Metawater Co Ltd
OTGLF76.00N/A
N/A
CD Projekt SA
XPRCF0.01N/A
N/A
XPLORE RES CORP.

PBYI and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBYI has been loosely correlated with AURA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PBYI jumps, then AURA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBYI
1D Price
Change %
PBYI100%
+0.60%
AURA - PBYI
37%
Loosely correlated
-0.16%
ACIU - PBYI
37%
Loosely correlated
-2.90%
COGT - PBYI
37%
Loosely correlated
-3.14%
RGNX - PBYI
36%
Loosely correlated
-4.11%
VYGR - PBYI
35%
Loosely correlated
-0.34%
More

VYGR and

Correlation & Price change

A.I.dvisor indicates that over the last year, VYGR has been loosely correlated with RGNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if VYGR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYGR
1D Price
Change %
VYGR100%
-0.34%
RGNX - VYGR
52%
Loosely correlated
-4.11%
TRDA - VYGR
52%
Loosely correlated
-1.57%
KYMR - VYGR
50%
Loosely correlated
-3.48%
XNCR - VYGR
48%
Loosely correlated
-3.10%
IMNM - VYGR
48%
Loosely correlated
-0.23%
More